One woman shares about the narcolepsy symptoms that disrupted her life, and the journey to a diagnosis: "I'm living proof you ...

Anecdotal evidence has long suggested that sleep problems are especially common for people with Moebius syndrome. Now, a new ...

HC Wainwright issued their Q1 2025 earnings estimates for shares of Jazz Pharmaceuticals in a research note issued to investors on Monday, March 10th. HC Wainwright analyst O. Livnat forecasts that ...

Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) had its price target upped by HC Wainwright from $200.00 to $217.00 in a ...

In addition to excessive daytime sleepiness, up to 60% of narcolepsy cases include cataplexy, which is a sudden loss of muscle control. When patients experience intense emotion, either positive or ...

We found that, compared to the general U.S. population, adults with Moebius syndrome had higher rates of probable sleep-disordered breathing, insomnia, cataplexy (i.e., sudden muscle weakness in ...

Axsome Therapeutics’ AXSM Auvelity (AXS-05) was launched in the United States in 2022 for the treatment of major depressive disorder (MDD), making it the first approved drug in the company’s portfolio ...

Each year there is a World Sleep Day and it's on Friday 14th March. The theme for this year is Making Healthy Sleep a ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Pharmaceuticals industry for Monday, March 10, 2025. Let’s take ...

Share on Pinterest Despite a unanimous scientific consensus, health experts are once again defending the safety of childhood vaccines and so-called autism risk. Sean Locke/Stocksy United Despite a ...

After hours: March 7 at 6:38:36 PM EST Loading Chart for NLSP ...

After hours: March 12 at 6:23:59 p.m. EDT Loading Chart for JAZZ ...